scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/ploscb/ZhangDS06 |
P356 | DOI | 10.1371/JOURNAL.PCBI.0020013 |
P932 | PMC publication ID | 1364505 |
P698 | PubMed publication ID | 16485037 |
P5875 | ResearchGate publication ID | 7292197 |
P50 | author | Jeffrey Skolnick | Q17516035 |
P2093 | author name string | Yang Zhang | |
Mark E Devries | |||
P2860 | cites work | Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the mu opioid receptor | Q44351857 |
Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain | Q44355525 | ||
Important amino acids for the function of the human MT1 melatonin receptor. | Q44430766 | ||
Mutagenesis studies of the human MT2 melatonin receptor | Q44491221 | ||
The ligand binding site of the formyl peptide receptor maps in the transmembrane region | Q73900183 | ||
Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier | Q74296792 | ||
Differential mechanisms of recognition and activation of interleukin-8 receptor subtypes | Q77335998 | ||
Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation | Q77808306 | ||
C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor | Q44497618 | ||
Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor | Q44786762 | ||
Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor | Q45154618 | ||
Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry | Q45742209 | ||
Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction | Q46158410 | ||
Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment | Q46970244 | ||
Species selectivity of nonpeptide antagonists of the gonadotropin-releasing hormone receptor is determined by residues in extracellular loops II and III and the amino terminus | Q47448039 | ||
BUNDLE: a program for building the transmembrane domains of G-protein-coupled receptors | Q47742352 | ||
Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1. | Q48964677 | ||
TASSER: an automated method for the prediction of protein tertiary structures in CASP6. | Q51963686 | ||
A scoring function for docking ligands to low-resolution protein structures. | Q51980288 | ||
Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. | Q52043997 | ||
How Well is Enzyme Function Conserved as a Function of Pairwise Sequence Identity? | Q52956083 | ||
Membrane proteins | Q57807155 | ||
Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G Protein | Q59942394 | ||
Two basic amino acids in the second inner loop of the interleukin-8 receptor are essential for Galpha16 coupling | Q73735495 | ||
Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling | Q22010723 | ||
Finishing the euchromatic sequence of the human genome | Q22122488 | ||
The protein structure prediction problem could be solved using the current PDB library | Q22248093 | ||
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle | Q22253922 | ||
The Protein Data Bank | Q24515306 | ||
TM-align: a protein structure alignment algorithm based on the TM-score | Q24522708 | ||
CDD: a Conserved Domain Database for protein classification | Q24795306 | ||
Crystal structure of rhodopsin: A G protein-coupled receptor | Q27625972 | ||
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor | Q27627995 | ||
Protein secondary structure prediction based on position-specific scoring matrices | Q27860483 | ||
Comparative protein structure modeling of genes and genomes | Q27860712 | ||
Comparative protein modelling by satisfaction of spatial restraints | Q27860866 | ||
Mapping the protein universe | Q27861112 | ||
Drug discovery: a historical perspective | Q28138834 | ||
Protein structure prediction and structural genomics | Q28190526 | ||
Identification of G protein-coupled receptor genes from the human genome sequence | Q28202262 | ||
Mapping of a ligand-binding site for the human thromboxane A2 receptor protein | Q28205029 | ||
A Method to Identify Protein Sequences That Fold into a Known Three-Dimensional Structure | Q28282741 | ||
Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops | Q28295751 | ||
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5 | Q28344177 | ||
GPCRDB: an information system for G protein-coupled receptors | Q28679239 | ||
The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints | Q29547321 | ||
RASMOL: biomolecular graphics for all | Q29547757 | ||
Scoring function for automated assessment of protein structure template quality | Q29615862 | ||
Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions | Q29616398 | ||
Protein structure prediction by global optimization of a potential energy function. | Q30322315 | ||
Structural genomics and its importance for gene function analysis. | Q30326344 | ||
Local energy landscape flattening: parallel hyperbolic Monte Carlo sampling of protein folding. | Q30331169 | ||
TOUCHSTONE II: a new approach to ab initio protein structure prediction | Q30333234 | ||
Assessment of homology-based predictions in CASP5. | Q30336223 | ||
Critical assessment of methods of protein structure prediction (CASP)-round V. | Q30336229 | ||
Automated structure prediction of weakly homologous proteins on a genomic scale | Q30341442 | ||
A model recognition approach to the prediction of all-helical membrane protein structure and topology | Q30420917 | ||
Automated method for modeling seven-helix transmembrane receptors from experimental data | Q30423649 | ||
What is the probability of a chance prediction of a protein structure with an rmsd of 6 A? | Q30430314 | ||
High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening | Q31063961 | ||
Development and large scale benchmark testing of the PROSPECTOR_3 threading algorithm | Q31086785 | ||
PREDICT modeling and in-silico screening for G-protein coupled receptors. | Q31107931 | ||
Tyrosine 220 in the 5th transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368. | Q31442619 | ||
Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. | Q32066951 | ||
The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287. | Q32125508 | ||
The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998. | Q32178008 | ||
Modelling G-protein-coupled receptors for drug design | Q33766736 | ||
Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates | Q33817249 | ||
Tertiary structure predictions on a comprehensive benchmark of medium to large size proteins | Q34187374 | ||
Prediction of structure and function of G protein-coupled receptors | Q34188824 | ||
Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3Adenosine Receptor | Q34190610 | ||
Regulation of corticotropin-releasing hormone in vitro | Q34241345 | ||
SPICKER: a clustering approach to identify near-native protein folds | Q34304367 | ||
Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay. | Q34418452 | ||
Four amino acid residues are critical for high affinity binding of neuromedin B to the neuromedin B receptor | Q34472389 | ||
The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop | Q34504076 | ||
Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? | Q35033301 | ||
Modeling the 3D structure of GPCRs: advances and application to drug discovery | Q35166029 | ||
Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. | Q36201452 | ||
Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands. | Q36342342 | ||
Optimal bundling of transmembrane helices using sparse distance constraints | Q36526243 | ||
Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells | Q36823316 | ||
G protein-coupled receptors: in silico drug discovery in 3D. | Q37388375 | ||
Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding | Q38316857 | ||
Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis | Q38336040 | ||
Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket | Q38352900 | ||
Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity | Q38920578 | ||
Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry | Q38977702 | ||
Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization | Q39147310 | ||
Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry | Q39355101 | ||
Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity | Q39413074 | ||
The second extracellular loop of CCR5 is the major determinant of ligand specificity. | Q39427062 | ||
CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins | Q39577767 | ||
Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. | Q39579651 | ||
Agonist-induced conformational changes in thyrotropin-releasing hormone receptor type I: disulfide cross-linking and molecular modeling approaches. | Q40458709 | ||
Specific cross-linking of Lys233 and Cys235 in the mu opioid receptor by a reporter affinity label. | Q40458735 | ||
Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist. | Q40467514 | ||
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site. | Q40468378 | ||
Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions. | Q40475616 | ||
Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding. | Q40496239 | ||
Locating ligand-binding sites in 7TM receptors by protein engineering. | Q40535098 | ||
Identification of amino acid residues crucial for chemokine receptor dimerization. | Q40600436 | ||
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach | Q40638101 | ||
Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression | Q40741689 | ||
Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES. | Q40796177 | ||
Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. | Q40850596 | ||
Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling | Q41216013 | ||
Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain | Q41528501 | ||
Accurate reconstruction of all-atom protein representations from side-chain-based low-resolution models | Q41755871 | ||
Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. | Q42819583 | ||
Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor | Q43575330 | ||
Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy | Q43792236 | ||
Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor | Q44022510 | ||
Identification of cysteines involved in ligand binding to the human melatonin MT(2) receptor | Q44090372 | ||
Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? | Q44242205 | ||
The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. | Q44259028 | ||
Identification of residues important for ligand binding of thromboxane A2 receptor in the second extracellular loop using the NMR experiment-guided mutagenesis approach | Q44292843 | ||
Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation | Q44342096 | ||
Exploring deltorphin II binding to the third extracellular loop of the delta-opioid receptor | Q44344725 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | protein structure | Q735188 |
G protein-coupled receptor | Q38173 | ||
P304 | page(s) | e13 | |
P577 | publication date | 2006-02-17 | |
P1433 | published in | PLOS Computational Biology | Q2635829 |
P1476 | title | Structure modeling of all identified G protein-coupled receptors in the human genome | |
P478 | volume | 2 |
Q42037742 | A generalized born implicit-membrane representation compared to experimental insertion free energies. |
Q37578268 | Advances in the Development and Application of Computational Methodologies for Structural Modeling of G-Protein Coupled Receptors. |
Q30371911 | Alpha-helical topology prediction and generation of distance restraints in membrane proteins. |
Q38089807 | An overview of recent developments in GPCR modelling: methods and validation |
Q36859642 | Are predicted protein structures of any value for binding site prediction and virtual ligand screening? |
Q30412875 | Automated protein structure modeling with SWISS-MODEL Workspace and the Protein Model Portal |
Q34040043 | BSP-SLIM: a blind low-resolution ligand-protein docking approach using predicted protein structures |
Q30369481 | Benchmarking of TASSER_2.0: an improved protein structure prediction algorithm with more accurate predicted contact restraints |
Q24658283 | Binding modes of CCR5-targetting HIV entry inhibitors: partial and full antagonists |
Q46885886 | Biochemistry. Signaling across the cell membrane |
Q37429729 | Chemokine receptors and other G protein-coupled receptors |
Q37700209 | Cholesterol modulates the dimer interface of the β₂-adrenergic receptor via cholesterol occupancy sites |
Q37385132 | Comparative analysis of GPCR crystal structures |
Q35048508 | Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia |
Q30380431 | Computational analysis of membrane proteins: the largest class of drug targets. |
Q26995693 | Computational modeling of membrane proteins |
Q30361594 | Computational prediction of atomic structures of helical membrane proteins aided by EM maps. |
Q37952425 | Computational studies of membrane proteins: models and predictions for biological understanding |
Q89518414 | Conformational plasticity of ligand-bound and ternary GPCR complexes studied by 19F NMR of the β1-adrenergic receptor |
Q28533596 | Differential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptors |
Q30401700 | Discrimination of Native-like States of Membrane Proteins with Implicit Membrane-based Scoring Functions. |
Q34049826 | Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? |
Q48590212 | Docking studies of novel pyrazinopyridoindoles class of antihistamines with the homology modelled H(1)-receptor. |
Q39121106 | Endothelial progenitor cells: Exploring the pleiotropic effects of statins |
Q35188834 | Enhanced Inter-helical Residue Contact Prediction in Transmembrane Proteins |
Q34265152 | FINDSITE(X): a structure-based, small molecule virtual screening approach with application to all identified human GPCRs |
Q60956605 | FSHR Trans-Activation and Oligomerization |
Q30390297 | FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A. |
Q26829909 | G protein regulation of neuronal calcium channels: back to the future |
Q30437388 | GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex |
Q55564362 | GPCR Conformations: Implications for Rational Drug Design. |
Q34485830 | GPCR-I-TASSER: A Hybrid Approach to G Protein-Coupled Receptor Structure Modeling and the Application to the Human Genome |
Q33909144 | GPCR-SSFE: a comprehensive database of G-protein-coupled receptor template predictions and homology models |
Q34413389 | GPCRRD: G protein-coupled receptor spatial restraint database for 3D structure modeling and function annotation |
Q59042560 | GPCRs: Lipid-Dependent Membrane Receptors That Act as Drug Targets |
Q46623168 | Ggamma1 + Ggamma2 not equal to Gbeta: heterotrimeric G protein Ggamma-deficient mutants do not recapitulate all phenotypes of Gbeta-deficient mutants. |
Q24657484 | High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor |
Q35172794 | High-resolution modeling of transmembrane helical protein structures from distant homologues |
Q24605680 | I-TASSER: a unified platform for automated protein structure and function prediction |
Q64066927 | Identification and Characterization of a Luteinizing Hormone Receptor (LHR) Homolog from the Chinese Mitten Crab |
Q39865678 | Identification and functional analysis of novel variants of the human melanocortin 1 receptor found in melanoma patients. |
Q33264967 | Identification of a gonadotropin-releasing hormone receptor orthologue in Caenorhabditis elegans |
Q36922640 | Identification of novel arthropod vector G protein-coupled receptors |
Q33415692 | Improving consensus structure by eliminating averaging artifacts |
Q47094111 | Improving virtual screening of G protein-coupled receptors via ligand-directed modeling. |
Q34735557 | In silico study on binding specificity of gonadotropins and their receptors: design of a novel and selective peptidomimetic for human follicle stimulating hormone receptor. |
Q46724888 | Internet resources in GPCR modelling. |
Q33347810 | Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening |
Q50698696 | MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. |
Q46664794 | Melatonin potentiates rod signals to ON type bipolar cells in fish retina. |
Q30424545 | Membrane protein native state discrimination by implicit membrane models |
Q48178221 | Model quality assessment for membrane proteins |
Q57207084 | Modeling and Validation of Transmembrane Protein Structures |
Q39310535 | Modeling of mammalian olfactory receptors and docking of odorants |
Q50854147 | Modeling the interactions between MC2R and ACTH models from human. |
Q51603697 | Molecular Modelling of G Protein-Coupled Receptors Through the Web. |
Q42754544 | Molecular dynamics simulations on the Tre1 G protein-coupled receptor: exploring the role of the arginine of the NRY motif in Tre1 structure |
Q38845232 | Molecular recognition in the sphingosine 1-phosphate receptor family |
Q48286361 | NOBEL 2012 Chemistry: Studies of a ubiquitous receptor family. |
Q50596439 | OMPcontact: An Outer Membrane Protein Inter-Barrel Residue Contact Prediction Method. |
Q62599579 | Open-Boundary Molecular Mechanics/Coarse-Grained Framework for Simulations of Low-Resolution G-Protein-Coupled Receptor-Ligand Complexes |
Q33732145 | Optimizing structural modeling for a specific protein scaffold: knottins or inhibitor cystine knots |
Q30379331 | Performance of the Pro-sp3-TASSER server in CASP8 |
Q41295163 | Phenotypic effects of Ehlers-Danlos syndrome-associated mutation on the FnIII domain of tenascin-X. |
Q30377334 | PoLi: A Virtual Screening Pipeline Based on Template Pocket and Ligand Similarity. |
Q30374712 | Prediction of membrane protein structures with complex topologies using limited constraints |
Q30375840 | Protein structure prediction: when is it useful? |
Q37304442 | Q-Dock: Low-resolution flexible ligand docking with pocket-specific threading restraints |
Q34607766 | RETRACTED: Structural basis for nucleotide exchange on G alpha i subunits and receptor coupling specificity |
Q43103617 | RHYTHM--a server to predict the orientation of transmembrane helices in channels and membrane-coils |
Q28548290 | RNA-Seq Analysis of Human Trigeminal and Dorsal Root Ganglia with a Focus on Chemoreceptors |
Q33477573 | Signal transduction profiling using label-free biosensors |
Q42712396 | Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor |
Q44431073 | Site-directed mutagenesis and PBAN activation of the Helicoverpa zea PBAN-receptor. |
Q26783016 | Structural Studies of G Protein-Coupled Receptors |
Q28469177 | Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage |
Q57015852 | Structure and Modeling of GPCRs: Implications for Drug Discovery |
Q33736866 | Structure prediction of the second extracellular loop in G-protein-coupled receptors |
Q34023834 | The E92K melanocortin 1 receptor mutant induces cAMP production and arrestin recruitment but not ERK activity indicating biased constitutive signaling |
Q44339249 | The full-length mu-opioid receptor: a conformational study by circular dichroism in trifluoroethanol and membrane-mimetic environments |
Q35264433 | The significance of G protein-coupled receptor crystallography for drug discovery |
Q36023705 | Toward high-resolution prediction and design of transmembrane helical protein structures |
Q30352431 | Transmembrane protein alignment and fold recognition based on predicted topology |
Q64068088 | Understanding Ligand Binding to G-Protein Coupled Receptors Using Multiscale Simulations |
Q36716343 | patGPCR: a multitemplate approach for improving 3D structure prediction of transmembrane helices of G-protein-coupled receptors |
Search more.